Team Cervivor Attends ASCO 2024

The American Society of Clinical Oncology (ASCO) Annual Meeting is a premier event in the oncology community, gathering thousands of professionals from around the globe to discuss groundbreaking research, innovative treatments, and the future of cancer care. This year, Team Cervivor attended ASCO 2024, marking a significant milestone for our organization and highlighting the critical role of patient advocates in the fight against cancer.

What is ASCO?
ASCO, founded in 1964, is a leading professional organization for physicians and oncology professionals. Its mission is to conquer cancer through research, education, and the promotion of the highest quality patient care. The annual ASCO meeting is the largest of its kind, offering a platform for the latest scientific advancements, policy discussions, and networking opportunities. Attendees include oncologists, researchers, pharmaceutical representatives, and patient advocates, all united in their dedication to improving cancer care.

Our presence at ASCO 2024 was a testament to the growing recognition of the importance of patient voices in shaping cancer care and research. Here’s why our participation matters:

  1. Amplifying Patient Voices: As patient advocates, we bring the perspectives and experiences of those directly affected by cervical cancer. Our stories and insights are invaluable in guiding research priorities and improving patient care practices.
  2. Cultivating Collaboration: Attending ASCO allows us to collaborate with researchers, clinicians, and other advocacy groups. These interactions help us stay informed about the latest advancements and ensure that patient needs are at the forefront of scientific discussions.
  3. Promoting Awareness and Education: By engaging with the oncology community, we can spread awareness about cervical cancer, highlight the importance of prevention and early detection, and share our educational resources. Our presence at ASCO reinforces the message that cervical cancer is preventable and treatable when caught early.
  1. Influencing Policy and Research: Our participation at ASCO provides opportunities to advocate for policies that benefit cervical cancer patients and survivors. We can also contribute to shaping research agendas by emphasizing areas that require more attention, such as disparities in cancer care and the psychosocial impacts of the disease.

Team Cervivor Listed from Left to Right: Morgan Newman, MSW, Community Engagement Liaison; Tamika Felder, Founder & Chief Visionary; and Kimberly Williams, MHCM, Chief Diversity Equity & Inclusion Officer

Highlights from ASCO 2024
ASCO 2024 was a whirlwind of inspiring sessions, groundbreaking research presentations, and meaningful interactions. Here are some highlights from our experience:

Networking Opportunities: We connected with oncologists, researchers, and fellow advocates, nurturing relationships that will strengthen our advocacy efforts. These connections are crucial for creating a supportive network dedicated to cervical cancer eradication.

Media and Outreach: We participated in interviews, highlighting the importance of patient advocacy and the work we do. These media opportunities allowed us to reach a broader audience and amplify our message.

We also had the honor of having our Founder and Chief Visionary, Tamika Felder, speak on a crucial panel titled, “Bridging the Gap in Cancer Care for Adolescents and Young Adults” hosted by The Atlantic. This enlightening session shed light on the challenges faced by the nearly 1.5 million adolescents and young adults diagnosed with cancer each year. Addressing issues such as work, health insurance, school, fertility, and emotional distress, the panel explored the unique cancer biology of this age group and the lack of survival improvements compared to other age demographics. Tamika, alongside other survivors, oncologists, and advocates, shared her journey and insights, emphasizing the importance of tailored care and pioneering local programs that support the distinct needs of young cancer patients. Her participation underscored Team Cervivor’s commitment to advocating for comprehensive and compassionate cancer care for all age groups.

Attending ASCO 2024 was more than just an opportunity to learn and network; it was a chance to reaffirm our commitment to the mission to end cervical cancer. We left the conference inspired and energized, ready to continue our mission with renewed vigor. Our presence at ASCO underscores the vital role of patient advocates in the oncology community, and we are proud to be a voice for cervical cancer patients and survivors worldwide.

As we move forward, we will leverage the knowledge and connections gained at ASCO to enhance our educational programs, support initiatives, and advocacy efforts. Together, we can make a difference in the lives of those affected by cervical cancer and work towards a future free of this preventable disease. Stay tuned for more updates from Team Cervivor and join us in our journey to eradicate cervical cancer. Together, we are stronger, and together, we can achieve a world without cervical cancer.

PRESS RELEASE: Cervivor Founder and Chief Visionary, Tamika Felder Invited to Share Opening Remarks for First Lady, Dr. Jill Biden and the American Cancer Society’s Launch of The National Breast and Cervical Cancer Roundtables

WASHINGTON, D.C. – In February 2022, the American Cancer Society announced they would be launching two national roundtables: one for cervical cancer and the other for breast cancer. This was a response to President Biden’s call to action in reducing cancer incidence and death rates faster. This initiative is to bring together leading organizations and experts in the cervical and breast cancer space to drive progress and improve the lives of cancer patients, as well as their families.

The objectives of the national roundtables align with the President’s Cancer Panel’s report Closing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access

The report addresses the need to:

  • Improve and Align Communication: Develop effective communications about cancer screening that reach all populations; and expand and strengthen National Cancer Roundtables that include a focus on cancer screening.
  • Facilitate Equitable Access: Barriers contribute to lower rates of cancer screening initiation and the recommended follow-up observed among many populations in the United States; there is a need to provide and sustainably fund community-oriented outreach and support services to promote appropriate screening and follow-up care plus increase access to self-sampling for cancer screening.
  • Strengthen Workforce Collaborations: Team-based care has the potential to improve implementation of cancer screening but in order to accomplish this, supportive policies and a commitment to team-based care approaches are needed which include the empowerment of healthcare team members to support screening plus having the opportunity for training and residency programs; and expanding access to genetic testing and counseling for cancer risk assessments to catch cancer early.
  • Create effective health IT: Providers and patients alike are faced with more information than they can process in a reasonable amount of time. Health information technology (IT) has potential to help providers, patients, and healthcare systems quickly access and effectively use clinical knowledge and patient-specific data.

Cervivor Founder and Chief Visionary, Tamika Felder was invited to speak on behalf of cervical cancer patient advocates and their families to increase awareness, impact change, and work collectively towards eliminating cervical cancer. Tamika and Cervivor, Inc. have been long-standing influencers on the panel since 2003, helping to provide vision as well as patient stories. She shares, “For me it is personal. My legacy won’t be the lives that I bring into this world but the lives I will save.”

First Lady Jill Biden attends an American Cancer Society Roundtable event, Monday, October 24, 2022, in the State Dining Room of the White House. (Official White House Photo by Adam Schultz)

Recording artist and cancer prevention advocate, Mary J. Blige shared the personal impact cancer has had on her family in recent years and why she has dedicated so much time to awareness. She phrases a key message, “I’ve dedicated time to making people understand their health is their wealth and urging them to make it a priority.”

American Cancer Society CEO, Dr. Karen Knudsen states, “We at the American Cancer Society represent all 1.9 million Americans that hear each year that they will have cancer and we are absolutely resonating with the goal of the Cancer Moonshot to end cancer as we know it.”

Dr. Karen Knudsen, Tamika Felder, First Lady Dr. Jill Biden, and Mary J. Blige

Dr. Knudsen also brings to light that breast cancer still remains to be the second leading cause of cancer death for women in this country and number one for Black and Latina women. 14,000+ women are diagnosed with cervical cancer and over 4,000 will die from the disease. Black and Latina women are again, impacted at nearly twice the rate as their Caucasian peers.

First Lady, Dr. Biden emphasizes there should be no woman left behind. There is an absolute need for collaborative efforts including the patient advocate voice because this impacts us all. The focus is to put patients and their families at the center of their cancer – from diagnosis to survivorship and we are rewriting the narrative of cancer.

“We don’t have to be afraid of cancer anymore!” 

We stand with the First Lady, the American Cancer Society, and so many more leading organizations. We are committed to this mission as we are reminded of the daily impact in our community of a cervical cancer diagnosis, the treatment and difficulties in survivorship, and of those lives that have been lost from a preventable disease.  

Watch the full livestream recording here.